Inhibitors of cyclooxygenase-2: November 1999 - April 2000
- 1 July 2000
- journal article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 10 (7), 1011-1020
- https://doi.org/10.1517/13543776.10.7.1011
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Selective cyclooxygenase-2 inhibitors as non-ulcerogenic anti-inflammatory agentsExpert Opinion on Therapeutic Patents, 1999
- Recently reported inhibitors of cyclooxygenase-2Expert Opinion on Therapeutic Patents, 1998
- Prostaglandin synthase 2Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain.Proceedings of the National Academy of Sciences of the United States of America, 1994
- Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.Proceedings of the National Academy of Sciences of the United States of America, 1994
- Gastrointestinal Damage Associated with the Use of Nonsteroidal Antiinflammatory DrugsThe New England Journal of Medicine, 1992
- Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme.Proceedings of the National Academy of Sciences of the United States of America, 1992
- Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice.JCI Insight, 1990
- Renal Side Effects of Nonsteroidal Antiinflammatory Drugs: Clinical RelevanceAmerican Journal of Kidney Diseases, 1986
- Renal Syndromes Associated with Nonsteroidal Antiinflammatory DrugsThe New England Journal of Medicine, 1984